Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Amortization of Deferred Charges (2015 - 2024)

Updated

Analysis

Skye Bioscience (SKYE) Amortization of Deferred Charges (2015 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 3,063.00
Jun 30, 2024 6,874.00
Mar 31, 2024 237,205.00
Dec 31, 2023 227,490.00
Sep 30, 2023 2,813.00
Dec 31, 2022 9,129.00
Sep 30, 2022 459.00
Jun 30, 2022 444.00
Mar 31, 2022 154,836.00
Dec 31, 2021 154,749.00
Sep 30, 2021 420.00
Jun 30, 2021 406.00
Mar 31, 2021 141,490.00
Dec 31, 2020 141,409.00
Sep 30, 2020 384.00
Jun 30, 2020 371.00
Mar 31, 2020 130,710.00
Dec 31, 2019 190,329.00
Sep 30, 2019 190,886.00
Jun 30, 2019 184,313.00
API Access

Skye Bioscience Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=SKYE&period=max&api_key=YOUR_API_KEY